Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months ended April 1, 2012 after the market close on Tuesday, May 8, 2012. The Company also announced that Doug Kohrs, President and Chief Executive Officer, and Carmen Diersen, Chief Financial Officer, will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier invites all interested parties to join the call by dialing (877) 673-5355 for domestic participants and (760) 666-3805 for international participants. The call will also be broadcast live over the Internet and can be accessed on the Investors Relations section of the Company’s website at www.tornier.com. A telephone replay will be available for two weeks following the call by dialing (855) 859-2056 for domestic participants and (404) 537-3406 for international participants. When prompted, please enter the replay pin number 70742010. For those who are not available to listen to the live webcast, the call will be archived for one year on Tornier’s website. About Tornier Tornier is a global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's broad offering of approximately 90 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier's "Specialists Serving Specialists" philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopedic technology stemming from its close collaboration with orthopedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit www.tornier.com.